MEK Inhibition in a Newborn with <i>RAF1</i>-Associated Noonan Syndrome Ameliorates Hypertrophic Cardiomyopathy but Is Insufficient to Revert Pulmonary Vascular Disease.
第一作者:
Alessandro,Mussa
第一单位:
Department of Public Health and Pediatric Sciences, University of Torino, 10126 Torino, Italy.;Clinical Pediatric Genetics Unit, Regina Margherita Children's Hospital, Città Della Salute e Della Scienza di Torino, 10126 Torino, Italy.
作者:
主题词
心肌病, 肥厚性(Cardiomyopathy, Hypertrophic);致命性结局(Fatal Outcome);女(雌)性(Female);人类(Humans);高血压, 肺性(Hypertension, Pulmonary);婴儿, 新生(Infant, Newborn);MAP激酶激酶激酶类(MAP Kinase Kinase Kinases);努南综合征(Noonan Syndrome);蛋白激酶抑制剂(Protein Kinase Inhibitors);原癌基因蛋白质c-raf(Proto-Oncogene Proteins c-raf)
DOI
10.3390/genes13010006
PMID
35052347
发布时间
2022-12-07
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文